10x Science
YC W26San Francisco, US · Founded 2025 · 5 employees · Hiring · 4 known investors
10x Science provides an AI platform that automates protein characterization for drug developers, reducing months of manual analysis to speed the evaluation of therapeutic candidates in early-stage development.
AI & Machine LearningBiotechEnterprise SoftwareSaaSB2BAIUnited States of AmericaAmerica / CanadaPartly Remote
Founders & leadership· Y Combinator alumni (W26)
10x Science was founded in 2025 by David Roberts, Andrew Reiter, and Vishnu Tejus.
DR
David Robertsin𝕏Founder and CEODavid Roberts holds a B.S. in chemistry and mathematics from UC San Diego and a Ph.D. in materials and analytical chemistry from the University of Wisconsin-Madison. He completed postdoctoral research in chemical biology at Stanford University as a Damon Runyon Cancer Research Fellow.
AR
Andrew ReiterinFounder and COOAndrew Reiter holds a B.S. in Biology from UNC-Chapel Hill and completed a Ph.D. in Biology at Stanford University under the co-advising of Carolyn Bertozzi and Or Gozani. He previously worked at the Broad Institute developing mass spectrometry methods in the Proteomics Platform Lab.
VT
Vishnu Tejusin𝕏Founder and CTOVishnu Tejus founded Nooks as a second hire and founding engineer, developing AI for go-to-market teams. He subsequently conducted research in analytical chemistry and cancer biology at the University of Washington, UCSF, and Stanford, publishing in peer-reviewed journals.
Investors · 4
Initialized CapitalSan Francisco · $1M – $5M
Y CombinatorSan Francisco · $500K
Civilization Ventures Management, LlcreportedTiburon · $1M – $10M
Also in the syndicate · 1
Founder Factor
Funding
SEC filings, press & company announcements$4.8M disclosed across 1 round · 2026
- $4.8MSeed FundingApr 2026 · 5 sources
Initialized Capital (lead), Civilization Ventures, Founder Factor, Y Combinator
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 2
by search overlap10x Genomics 1-color29 shared keywords10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers. The tools support applications in cancer, immunology, and neuroscience, enabling gene expression and multiomic profiling of cell surface protein, intracellular protein, and CRISPR guides.
10x Founders7 shared keywords10x Founders is an early-stage venture investor operating an international network of entrepreneurs and investors, primarily across Europe and the US. The firm backs early-stage startups, with its six partners having been early investors in companies such as Adyen, EquipmentShare, and Luminar.
Companies competing with 10x Science for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does 10x Science do?
- 10x Science provides an AI platform that automates protein characterization for drug developers, reducing months of manual analysis to speed the evaluation of therapeutic candidates in early-stage development.
- Who founded 10x Science?
- 10x Science was founded by David Roberts, Andrew Reiter, Vishnu Tejus in 2025.
- Who are 10x Science's investors?
- 10x Science's investors include Initialized Capital, Y Combinator, Civilization Ventures Management, Llc.
- How much funding has 10x Science raised?
- 10x Science has disclosed $4.8M raised across 1 round.
- Where is 10x Science headquartered?
- 10x Science is headquartered in San Francisco, US.